期刊： BEHAVIOURAL PHARMACOLOGY, 2021; 32 (7)
Patients diagnosed with schizophrenia have been reported to exhibit atypically low pain sensitivity and to vary in their experience of chronic pain. T......
期刊： BEHAVIOURAL PHARMACOLOGY, 2021; 32 (6)
Dezocine is an opioid with low efficacy at mu-opioid and kappa-opioid receptors. It also inhibits the reuptake of norepinephrine and serotonin. Dezoci......
期刊： BEHAVIOURAL PHARMACOLOGY, 2021; 32 (6)
Prepulse inhibition (PPI) refers to the inhibition of the startle reflex that occurs when the startling stimulus is preceded by a weak prestimulus. Al......
期刊： BEHAVIOURAL PHARMACOLOGY, 2021; 32 (1)
We have reported that SMIP004, an inhibitor of S-phase kinase-associated protein 2 (Skp2), displays antidepressant-like activities in stress-naive and......
期刊： BEHAVIOURAL PHARMACOLOGY, 2020; 31 (2-3)
The clinical use of opioid analgesics, such as morphine, is limited by analgesic tolerance, molecular mechanism of which is not well understood. Recen......
期刊： BEHAVIOURAL PHARMACOLOGY, 2020; 31 (2-3)
The Toll-like receptor 4 (TLR4) antagonists, (+)-naloxone and (+)-naltrexone, have been reported to decrease self-administration of opioids in rats an......
期刊： BEHAVIOURAL PHARMACOLOGY, 2020; 31 (4)
beta-hydroxybutyrate, a ketone body metabolite, has been shown to suppress depression-like behavior in rodents. In this study, we examined its antidep......
期刊： BEHAVIOURAL PHARMACOLOGY, 2020; 31 (6)
Posttraumatic stress disorder is a mental disorder with a known cause, yet effective behavioral and pharmacotherapies remain elusive for many afflicte......
期刊： BEHAVIOURAL PHARMACOLOGY, 2019; 30 (1)
Parkinson's disease (PD) causes major changes in dopaminergic neurons of the brain, resulting in motor symptoms in older adults. A previous study show......
期刊： BEHAVIOURAL PHARMACOLOGY, 2019; 30 (4)
Isolation rearing produces significant behavioral and neurochemical dysfunctions in rodents, which resemble the symptoms of schizophrenia. Clozapine, ......
期刊： BEHAVIOURAL PHARMACOLOGY, 2019; 30 (5)
Previous preclinical research suggests that l-methamphetamine (l-MA) has potential therapeutic utility to treat psychostimulant abuse. This study exam......
期刊： BEHAVIOURAL PHARMACOLOGY, 2019; 30 (6)
N-ethylpentylone (NEP), a new synthetic cathinone, has been rising to be one of the most popular cathinone derivatives in recent years. However, resea......
期刊： BEHAVIOURAL PHARMACOLOGY, 2019; 30 (8)
Chronic inflammation plays an important role in the mechanisms underpinning the development of anesthesia-induced cognitive dysfunction. However, less......
期刊： BEHAVIOURAL PHARMACOLOGY, 2019; 30 (8)
Piperlongumine, an alkaloid compound extracted from Peper longum L, has been reported to produce neuroprotective effects in the brain and exert variou......
期刊： BEHAVIOURAL PHARMACOLOGY, 2019; 30 (8)
The brain renin-angiotensin system plays a vital role in the modulation of the neuroinflammatory responses and the progression of dopaminergic (DA) de......
